BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3002577)

  • 1. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).
    Fisher ER; Sass R; Fisher B; Wickerham L; Paik SM
    Cancer; 1986 Jan; 57(2):197-208. PubMed ID: 3002577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is invasion a necessary step for metastases in breast cancer?
    Narod SA; Sopik V
    Breast Cancer Res Treat; 2018 May; 169(1):9-23. PubMed ID: 29353366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.
    Flanagan MR; Rendi MH; Gadi VK; Calhoun KE; Gow KW; Javid SH
    Ann Surg Oncol; 2015 Oct; 22(10):3264-72. PubMed ID: 26202556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification in ductal carcinoma in situ: the role of genomic testing.
    Freedman GM
    Curr Oncol Rep; 2013 Feb; 15(1):7-13. PubMed ID: 23180216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the breast: a surgical perspective.
    Badruddoja M
    Int J Surg Oncol; 2012; 2012():761364. PubMed ID: 22988495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.
    Zhou X; Meeker AK; Makambi KH; Kosti O; Kallakury BV; Sidawy MK; Loffredo CA; Zheng YL
    Carcinogenesis; 2012 Jan; 33(1):113-8. PubMed ID: 22072619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
    Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence.
    Barnes N; Haywood P; Flint P; Knox WF; Bundred NJ
    Br J Cancer; 2006 Jan; 94(2):253-8. PubMed ID: 16421596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Ductal Carcinoma In Situ (DCIS:noncomedo type)Detected by Ultrasonography: Demonstration of Occult Multiple Foci.
    Okamoto H; Hagiwara H; Naganuma H; Itakura J; Nagahori K; Fujii H; Yamamoto M; Sekikawa T; Matsumoto Y
    Breast Cancer; 1996 Jun; 3(2):145-150. PubMed ID: 11091568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Recurrence after Conservative Surgery for Breast Cancer.
    Takahashi M; Takahashi H; Suzuki H; Sasaki F; Hata Y; Inoue K; Uchino J
    Breast Cancer; 1996 Jun; 3(2):135-139. PubMed ID: 11091566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery.
    Noguchi M; Minami M; Earashi M; Taniya T; Miyazaki I; Mizukami Y; Nonomura A; Nishijima H; Takanaka T; Kawashima H; Saito Y; Takashima C; Nakamura S; Michigishi T; Yokoyama K
    Breast Cancer; 1995 Apr; 2(1):27-33. PubMed ID: 11091529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical decision-making in early breast cancer.
    Balch CM; Singletary SE; Bland KI
    Ann Surg; 1993 Mar; 217(3):207-25. PubMed ID: 8383953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ductal carcinoma in situ of the breast.
    Reynolds JV; Sweeney JP; Nolan N; Korebrits A; Duffy MJ; McDermott EW; O'Higgins NJ
    Ir J Med Sci; 1993 Feb; 162(2):45-8. PubMed ID: 8383101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of in situ and minimally invasive breast carcinoma.
    Frykberg ER; Bland KI
    World J Surg; 1994; 18(1):45-57. PubMed ID: 8197776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of carcinoma of the breast.
    Eberlein TJ
    Ann Surg; 1994 Aug; 220(2):121-36. PubMed ID: 8053734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.
    Fabian CJ; Zalles C; Kamel S; Kimler BF; McKittrick R; Tranin AS; Zeiger S; Moore WP; Hassanein RS; Simon C
    Breast Cancer Res Treat; 1994; 30(3):263-74. PubMed ID: 7981444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ductal carcinoma in situ of the breast.
    Carty NJ; Carter C; Royle GT; Johnson CD
    Ann R Coll Surg Engl; 1995 May; 77(3):163-7. PubMed ID: 7598411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic criteria in breast-saving surgery].
    Schauer A; Brehler R; Bergholz M
    Langenbecks Arch Chir; 1986; 369():427-36. PubMed ID: 3807557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary breast cancer without mastectomy. The Los Angeles community experience and review of the literature.
    Ann Surg; 1986 Aug; 204(2):136-47. PubMed ID: 3741005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.